IMCHECK THERAPEUTICS
LIVE

Serial Number

79265246

Owner

IMCHECK THERAPEUTICS

Attorney

Ben Natter

Filing Date

Apr 8, 2019

Add to watchlist:

No watchlists yet
View on USPTO

IMCHECK THERAPEUTICS Trademark

Serial Number: 79265246 • Registration: 6015897

IMCHECK THERAPEUTICS is a trademark filed by IMCHECK THERAPEUTICS on April 8, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

IMCHECK THERAPEUTICS (4 trademarks)

180 avenue du Prado

Entity Type: 34

Trademark Details

Filing Date

April 8, 2019

Registration Date

March 24, 2020

Published for Opposition

January 7, 2020

Goods & Services

[ Pharmaceutical and veterinary products, namely, veterinary pharmaceutical preparations for the prevention of autoimmune diseases and cancer, dermatological pharmaceutical products, and anti-infective products for veterinary use; medical and veterinary preparations, namely, diagnostic preparations for medical or veterinary purposes, and bacterial preparations for medical and veterinary use; biotechnological preparations for medical use, namely, biological preparations for the treatment of cancer and biological preparation for use in cell cultures other than for medical or veterinary use; chemical preparations for medical or pharmaceutical use, namely, for treatment of autoimmune diseases and cancer; sanitary products for medical purposes, namely, sanitary towels, sanitary napkins, sanitary tampons, sanitary pads, sanitary sterilizing preparations and sanitary preparations for medical use; vaccines; antibiotics; adjuvants for medical use; pharmaceutical preparations and substances for treatment of diseases and disorders, namely, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; biological substances for human medical diagnostics and analysis, namely, medical diagnostic reagents and diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; cultures and preparations of microorganisms for medical use; bacterial preparations for medical use; bacteriological preparations for medical use; biological preparations for medical use, namely, biological preparation for use in cell cultures other than for medical or veterinary use; pharmaceutical preparations for medical use, namely, pharmaceutical preparations for wounds, pharmaceutical preparations for skin care, and pharmaceutical preparations for treating allergies; stem cells for medical use; chemical preparations for medical use, namely, chemical preparations for sanitary use and chemical preparations for the diagnosis of pregnancy; enzyme preparations for medical use; dietetic foods for medical use, and dietetic substances for medical use, namely, diet pills and dietetic infusions for medical use; materials for dressings for medical purposes, namely, burn dressings, bandages for dressings, gauze for dressings, wound dressings, wadding for dressings, and medical dressings; material for dental fillings and dental impressions; disinfectants for medical use; disinfectants for medical or sanitary use, other than soaps; bath preparations for medical use; sanitary panties or napkins; medicinal herbs; herbal teas for medicinal purposes; parasiticides for medical use ]

Laboratory analysis services relating to the treatment of persons, namely, medical analysis services for the diagnosis of cancer; medical laboratory services for sample analysis, namely, medical sample analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services with respect to the treatment of persons provided by laboratories, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; [ medical services; medical diagnostic testing, monitoring and reporting services and medical therapy services, namely, physical therapy services and occupational therapy services; veterinary services; ] pharmaceutical advice; medical services in the nature of immunotherapy treatments; preparation and dispensing of medication; providing cancer screening services; ] providing medical information in the field of oncology [ and immunotherapy treatments ] ; providing medical information; [ providing medical assistance; ] providing medical advice in the field of cancer, [ autoimmune diseases and immunotherapy; ] medical information; information relating to health, namely, providing health information; advisory services relating to health, namely, consulting services in the field of health

Organization and conducting of educational conferences; organization and conducting of seminars and educational colloquiums; organization and conducting of educational symposiums; organization of educational exhibitions; organization of educational meetings in the field of education and training; training courses concerning research and development in the field of cancer [ , autoimmune diseases and immunotherapy; organization of special events in the nature of award ceremonies for providing recognition by the way of awards to demonstrate excellence in the field of research and treatment of cancer, autoimmune diseases and immunotherapy; copyediting of medical publications; publication of printed matter; publication of texts other than advertising texts; electronic publication of books and journals online ]

Scientific research and technical research in the field of pharmaceutical studies; [ evaluations and assessments in the fields of science and technology provided by engineers, namely, product quality evaluation for scientific and technological products provided by engineers; ] information relating to scientific research, namely, providing scientific research information in the field of cancer, autoimmune diseases and immunotherapy; medical research; [ biological research; clinical research in the nature of medical and scientific research, namely, conducting clinical trials for others; ] pharmaceutical research and product development research in the field of pharmaceutical products; [ scientific research in the field of chemistry and biochemistry; biotechnological research; medical research in the field of genetics; ] research and development for products in the medical field; providing scientific research services; [ scientific research services on behalf of third parties; ] medical research in the nature of analysis of human tissues for the purposes of medical research; [ research and development in the field of pharmaceuticals and biotechnology; scientific research in the field of molecular science; scientific research in the field of genetics; scientific research in the field of toxicity tests for scientific research purposes; providing advice with respect to scientific and medical research in the field of immunology and immunotherapy; ] analysis and research services in laboratories, namely, DNA analysis services for scientific research purposes, biological research, and chemical analysis; scientific laboratory services; medical research laboratory services, namely, medical research; [ provision of information in connection with medical and scientific research in the field of pharmaceutical products and clinical trials; conducting medical, pharmaceutical and scientific study programs, namely, conducting clinical trials for others; ] conducting clinical analyses and studies, namely, medical and scientific research in the nature of conducting clinical trials for others; laboratory testing services, namely, material testing and product testing; conducting clinical trials for others; [ conducting clinical trials for others in the fields of medicines, molecules and medical devices; ] providing information with respect to medical research

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jul 15, 2026 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Jul 15, 2026 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 29, 2026 APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 29, 2026 APRE
NEW REPRESENTATIVE AT IB RECEIVED
Jun 4, 2026 NREP
TEAS SECTION 71 & 15 RECEIVED
Mar 17, 2026 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 24, 2025 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 22, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 22, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 22, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 22, 2022 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 25, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 31, 2020 FICS
FINAL DISPOSITION PROCESSED
Jul 31, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 24, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jan 4, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 18, 2019 NONP
ASSIGNED TO LIE
Dec 4, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 3, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 22, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 21, 2019 TROA
REFUSAL PROCESSED BY IB
Sep 28, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 12, 2019 RFCS
REFUSAL PROCESSED BY MPU
Sep 12, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 31, 2019 RFCR
APPLICATION FILING RECEIPT MAILED
Aug 31, 2019 MAFR
NON-FINAL ACTION WRITTEN
Aug 30, 2019 CNRT
ASSIGNED TO EXAMINER
Aug 27, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 27, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 15, 2019 REPR